{"id":6081,"date":"2012-01-10T06:14:00","date_gmt":"2012-01-09T21:14:00","guid":{"rendered":"https:\/\/www.iir.hit-u.ac.jp\/en\/2012\/01\/10\/industry-academia-collaboration-workshop-on-process-and-strategy-in-biotechnology-innovation-2009-3-10\/"},"modified":"2012-01-10T06:14:00","modified_gmt":"2012-01-09T21:14:00","slug":"industry-academia-collaboration-workshop-on-process-and-strategy-in-biotechnology-innovation-2009-3-10","status":"publish","type":"post","link":"https:\/\/www.iir.hit-u.ac.jp\/en\/2012\/01\/10\/industry-academia-collaboration-workshop-on-process-and-strategy-in-biotechnology-innovation-2009-3-10\/","title":{"rendered":"Industry-Academia Collaboration Workshop on Process and Strategy in Biotechnology Innovation 2009.3.10"},"content":{"rendered":"<p><span style=\"color: #990000\"><b>\u25a0 Industry-Academia Collaboration Workshop on Process and Strategy in Biotechnology&nbsp;<\/b><\/span><b style=\"color: #990000\">&nbsp;Innovation<\/b><br \/><b style=\"color: #990000\"><br \/><\/b>March 10, 2009 at Roppongi Academy Hills 49F, Tokyo<br \/>Organized by&nbsp;IIR<br \/>Supported by&nbsp;Japan Bioindustry Association (JBA)<br \/>Japan Pharmaceutical Manufacturers Association (Office of Pharmaceutical Industry Research (OPIR))<br \/>New Energy and Industrial Technology Development Organization (NEDO)<\/p>\n<p>Opening Address<br \/>Seiichiro Yonekura (IIR)<\/p>\n<p>Session I: Government Support to the Commercialization of Scientific Discovery<br \/>Chair: Sadao Nagaoka (IIR)<\/p>\n<p>Keynote Speech 1: \u201cLessons from NIH SBIR Program\u201d<br \/>&nbsp; Charles Wessner (US National Academies)<br \/>&nbsp; Comment: Katsushi Takehiro (Ministry of Economy, Trade and Industry)<\/p>\n<p>Session II: Bio-based Innovation\u2014Issues as Seen from the Industry<br \/>Chair: Kentaro Nobeoka (IIR)<\/p>\n<p>Keynote Speech 2:\u201cExploiting the Biotechnology for Pharmaceutical Industry in Japan\u201d<br \/>&nbsp; Hiroshi Akimoto (University of Tokyo \/ Kyushu University \/ JPMA)<\/p>\n<p>Keynote Speech 3: \u201cOpportunities and Barriers to Biotechnology Firm Growth in Japan\u201d<br \/>&nbsp; Ichiro Nakatomi (NanoCarrier Co., Ltd.)<br \/>&nbsp; Comment: Gensuke Tokoro (aRigen Pharmaceuticals, Inc.)<br \/>&nbsp; &nbsp; &nbsp; &nbsp; Yaichi Aoshima (IIR)<\/p>\n<p>Session III: Mechanism of Commercialization of Biotechnology\u2014Bio-startups and Alliance (Report<br \/>of the findings of joint research)<br \/>Chair: Hiroyuki Chuma (IIR)<\/p>\n<p>(1) \u201cStrategic Alliance as an Alternative Strategy for Bio-ventures\u201d<br \/>&nbsp; Seiichiro Yonekura and Eyo Shiaw Jia (IIR)<br \/>&nbsp; &nbsp; &nbsp; Comment: Kiyokazu Yamazaki (Ichiyoshi Research Institute Inc.)<br \/>(2) \u201cEntry and Growth Performance of the Japanese Biotechnology Industry\u201d<br \/><span>  <\/span>Sadao Nagaoka (IIR), Yuji Honjo (Chuo University \/ IIR), Kenta Nakamura (Kobe University \/<br \/>&nbsp; IIR), Setsuo Morishita (JBA) and Yumi Shimizu (JBA)<br \/>&nbsp; &nbsp; &nbsp; Comment: Akihiko Shimauchi (M\u2019s Science Corporation)<br \/>(3) \u201cAlliance Strategy and Performance of Major Pharmaceutical Firms in US, Europe and Japan\u201d<br \/>&nbsp; Sadao Nagaoka, Kenta Nakamura, Yuji Honjo, Toshiro Takashima (OPIR)<br \/>&nbsp; &nbsp; &nbsp; Comment: &nbsp;Masayuki Tsuchiya (Chugai Pharmaceutical Co., Ltd.)<br \/>Closing Remarks:<br \/>Setsuo Morishita    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u25a0 Industry-Academia Collaboration Workshop on Process and Strategy in Biotechnology&nbsp;&nbsp;InnovationMarch 10, 2009 at Roppongi Academy Hills 49F, TokyoOrganized by&nbsp;IIRSupported by&nbsp;Japan Bioindustry Association (JBA)Japan Pharmaceutical Manufacturers Association (Office of Pharmaceutical Industry Research (OPIR))New Energy and Industrial Technology Development Organization (NEDO) Opening AddressSeiichiro Yonekura (IIR) Session I: Government Support to the Commercialization of Scientific DiscoveryChair: Sadao Nagaoka (IIR) Keynote Speech 1: \u201cLessons from NIH SBIR Program\u201d&nbsp; Charles Wessner (US National Academies)&nbsp; Comment: Katsushi Takehiro (Ministry of Economy, Trade and Industry) Session II: Bio-based Innovation\u2014Issues as Seen from the IndustryChair: Kentaro Nobeoka (IIR) Keynote Speech 2:\u201cExploiting the Biotechnology for Pharmaceutical Industry in Japan\u201d&nbsp; Hiroshi Akimoto (University of Tokyo \/ Kyushu University \/ JPMA)&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"vkexunit_cta_each_option":"","footnotes":""},"categories":[3,13],"tags":[],"class_list":["post-6081","post","type-post","status-publish","format-standard","hentry","category-conference","category-symposium"],"_links":{"self":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts\/6081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/comments?post=6081"}],"version-history":[{"count":0,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts\/6081\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/media?parent=6081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/categories?post=6081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/tags?post=6081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}